IBDEI2H7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41988,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,41988,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,41988,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,41989,0)
 ;;=D81.810^^159^2014^5
 ;;^UTILITY(U,$J,358.3,41989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41989,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,41989,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,41989,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,41990,0)
 ;;=E88.01^^159^2014^2
 ;;^UTILITY(U,$J,358.3,41990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41990,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,41990,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,41990,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,41991,0)
 ;;=J09.X1^^159^2014^25
 ;;^UTILITY(U,$J,358.3,41991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41991,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,41991,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,41991,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,41992,0)
 ;;=J09.X2^^159^2014^26
 ;;^UTILITY(U,$J,358.3,41992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41992,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,41992,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,41992,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,41993,0)
 ;;=J09.X3^^159^2014^27
 ;;^UTILITY(U,$J,358.3,41993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41993,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,41993,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,41993,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,41994,0)
 ;;=J09.X9^^159^2014^28
 ;;^UTILITY(U,$J,358.3,41994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41994,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,41994,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,41994,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,41995,0)
 ;;=J44.9^^159^2014^14
 ;;^UTILITY(U,$J,358.3,41995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41995,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,41995,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,41995,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,41996,0)
 ;;=J44.1^^159^2014^12
 ;;^UTILITY(U,$J,358.3,41996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41996,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,41996,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,41996,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,41997,0)
 ;;=J42.^^159^2014^10
 ;;^UTILITY(U,$J,358.3,41997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41997,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,41997,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,41997,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,41998,0)
 ;;=J43.9^^159^2014^22
 ;;^UTILITY(U,$J,358.3,41998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41998,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,41998,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,41998,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,41999,0)
 ;;=J43.0^^159^2014^30
 ;;^UTILITY(U,$J,358.3,41999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41999,1,3,0)
 ;;=3^MacLeod's Syndrome
 ;;^UTILITY(U,$J,358.3,41999,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,41999,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,42000,0)
 ;;=J43.1^^159^2014^21
 ;;^UTILITY(U,$J,358.3,42000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42000,1,3,0)
 ;;=3^Emphysema,Panlobular
 ;;^UTILITY(U,$J,358.3,42000,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,42000,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,42001,0)
 ;;=J43.2^^159^2014^19
 ;;^UTILITY(U,$J,358.3,42001,1,0)
 ;;=^358.31IA^4^2
